CA AB 407 (2021) Massively Expanded Optometry Scope — Anterior Segment Treatment, Oral Rx, Immunizations Including COVID Vaccines
AB 407 (Salas, signed 2021, effective Jan 1, 2022) significantly expanded California optometry scope. Authorized: treatment of all non-cancerous anterior-segment conditions; topical and oral non-controlled, non-glaucoma prescriptions; immunizations after immunization certification (flu, herpes zoster, pneumococcus, SARS-CoV-2); intense pulsed light, low-level light, intranasal stimulator, intracanalicular stents; assistants may perform subjective refraction (no Rx authority).
Companion bill AB 691 made COVID-19 vaccinations and clinical lab testing permanent. CA optometrists now have one of the broadest non-surgical OD scopes nationally — but laser/surgical scope remains off-limits after AB 2236 was VETOED by Gov. Newsom in Sept 2022 (3-year residency requirement cited).
For FQHCs: ODs can deliver more services per encounter, immunizations expand population health revenue, anterior segment scope reduces ophthalmology referrals.
Primary source
American Optometric AssociationSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2022, January 1). CA AB 407 (2021) Massively Expanded Optometry Scope — Anterior Segment Treatment, Oral Rx, Immunizations Including COVID Vaccines. Primary source: American Optometric Association. Retrieved July 30, 2026, from https://www.fqhctalent.com/intel/ca-ab-407-optometry-scope-expansion-2022
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge